Key result
Only ~14% of indicated AF patients receive pre-stroke anticoagulation despite clear clinical guidelines.
Why the study?
The study aimed to assess baseline clinical parameters of patients with atrial fibrillation and analyze the medications they were receiving at the onset of cardioembolic stroke from the standpoint of evidence-based cardiology.
Cross-Sectional (n=139)
No
Answers are grounded in this paper and cite their sources.
Th e aim of the research. To assess baseline clinical parameters of patients with atrial fi brillation and to analyse the whole variety of drugs they receive at the time of the development of cardioembolic stroke from the standpoint of evidence-based cardiology. Material and methods. Th e study was conducted at the premises of the neurological department for patients with acute cerebrovascular accidents of the Samara Regional Clinical Hospital named aft er V.D. Seredavin within the period from 2016 to 2019. In total, 139 patients were enrolled, of which 59 were male. Th e average age of the patients was 72.25±6.33. Results. Patients with atrial fi brillation admitted to the primary vascular department due to cardioembolic stroke were characterised by polymorbidity, namely: arterial hypertension was detected in 99.28 %, chronic kidney disease in 53.96 %, coronary heart disease in 30.94 %, diabetes mellitus in 19.42 % of the cases. Subjects with chronic atrial fi brillation prevailed among the studied patients (62.6 % of the cases). Th e risk of thromboembolic complications according to the CHA2DS2-VASc scale before admission to the hospital averaged at 4.37±1.2 points, while 97.84 % of the patients had indications for anticoagulant therapy. However, in real clinical practice, the prevention of thromboembolic complications was only carried out in 13.67 % of the cases and its quality was in compliancy with modern requirements in 3.60 % of the cases only. Conclusion. Th e data obtained attest to cardioembolic stroke developing in polymorbid patients with atrial fi brillation against the background of low quality management of patients with atrial fi brillation at the outpatient-polyclinic stage. Th is may indicate incomplete awareness of doctors about the possible risks of developing a feasibility study in patients with atrial fi brillation, as well as low patient adherence to treatment.
No takes yet. Share an insight, caveat, or question.
Efimova et al. (2022) conducted a cross-sectional in Atrial fibrillation and cardioembolic stroke (n=139). Outpatient oral anticoagulant therapy prior to stroke vs. Guideline-indicated anticoagulation (CHA2DS2-VASc ≥2) was evaluated on Receipt of pre-admission oral anticoagulant therapy among patients with atrial fibrillation and cardioembolic stroke. Outpatient anticoagulant therapy was prescribed to only 13.67% of atrial fibrillation patients prior to cardioembolic stroke, despite 97.84% having clinical indications for anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: